QMDT SEC-arkiveringar - Quick-Med Technologies, Inc.- Årsredovisning, Fullmaktsutlåtande, prospekt

Grundläggande statistik

CIK

1088206

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Quick-Med Technologies, Inc.

SEC Filings (Chronological Order)

Denna sida innehåller en komplett, kronologisk lista över SEC-arkiveringar, exklusive ägande-arkiveringar som vi tillhandahåller på andra ställen.

November 27, 2013	8-K	Regulation FD Disclosure, Financial Statements and Exhibits - QUICK MED TECHNOLOGIES 8-K 11-27-2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 27, 2013 QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Commission (IRS Employer
November 27, 2013	EX-99.1	MATCH POINT PARTNERS LLC 90 Park Avenue, Suite 1700 New York, NY 10016 Match Point Report on QMT History, Strategy and Near-Term Prospects Exhibit 99.1 MATCH POINT PARTNERS LLC 90 Park Avenue, Suite 1700 New York, NY 10016 Match Point Report on QMT History, Strategy and Near-Term Prospects This report includes forward-looking statements covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events, they are subject to various risks and uncertainties and actual results for fiscal year
November 13, 2013	15-12G	- QUICK-MED TECHNOLOGIES INC FORM 15-12G 11-13-2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
September 30, 2013	10-K	Annual Report - QUICK-MED TECHNOLOGIES, INC 10-K 6-30-2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x Annual Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended June 30, 2013 o Transition Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number: 000-27545 QUICK-MED TECHNOLOGIES, INC. (Name of issuer
September 12, 2013	8-K	Financial Statements and Exhibits, Other Events - QUICK-MED TECHNOLOGIES, INC 8-K 9-12-2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): 9/12/13 QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction of incorporation) (Commission File
September 12, 2013	EX-10.1	* © Quick-Med Technologies, Inc. Proprietary www.quickmedtech.com Company Overview September 2013 * © Quick-Med Technologies, Inc. Proprietary www.quickmedtech.com Safe Harbor Statement Forward Looking Statements This presentation contains forward-lo Exhibit 10.1 * © Quick-Med Technologies, Inc. Proprietary www.quickmedtech.com Company Overview September 2013 * © Quick-Med Technologies, Inc. Proprietary www.quickmedtech.com Safe Harbor Statement Forward Looking Statements This presentation contains forward-looking statements (statements which are not statements of historical facts). Any statements contained in this presentation that are not st
June 19, 2013	DEF 14C	- QUICK-MED TECHNOLOGIES INC DEF 14C 6-18-2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ¨ Preliminary Information Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) x Definitive Information Statement QUICK-MED TECHNOLOGIES, INC. (Name o
June 6, 2013	EX-99.1	Quick-Med Technologies Financial Community Update Conference Call Quick-Med update call scheduled for 11am ET on June 13, 2013 EX-99.1 2 ex991.htm EXHIBIT 99.1 Exhibit 99.1 News Release Quick-Med Technologies Financial Community Update Conference Call Quick-Med update call scheduled for 11am ET on June 13, 2013 Gainesville, Florida – June 5, 2013. Quick-Med Technologies, Inc. (OTCQB: QMDT), a life sciences company that is developing innovative technologies for the healthcare and consumer markets, will hold its Financial C
June 6, 2013	8-K	Regulation FD Disclosure, Financial Statements and Exhibits - QUICK MED TECHNOLOGIES 8-K 6-5-2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2013 (June 5, 2013) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Commission (I
May 29, 2013	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits - QUICK-MED TECHNOLOGIES INC 8-K 5-20-2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2013 (May 20, 2013) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction of incorporati
May 29, 2013	EX-10.1	AWARD/CONTRACT 1. THIS CONTRACT IS A RATED ORDER RATING PAGE OF PAGES UNDER DP AS (15 CFR 700) 1 \| 27 2. CONTRACT (Proc. Inst. Ident.) NO 3. EFFECTIVE DATE 4. REQUISITION/PURCHASE REQUEST/PROJECT NO W81XWH-13-C-0126 13 May 2013 0010274836-0002 5. ISS Exhibit 10.1 AWARD/CONTRACT 1. THIS CONTRACT IS A RATED ORDER RATING PAGE OF PAGES UNDER DP AS (15 CFR 700) 1 \| 27 2. CONTRACT (Proc. Inst. Ident.) NO 3. EFFECTIVE DATE 4. REQUISITION/PURCHASE REQUEST/PROJECT NO W81XWH-13-C-0126 13 May 2013 0010274836-0002 5. ISSUED BY CODE W81XWH 6. ADMINISTERED BY (If other than Item 5) CODE W81XWH USAMRAA US ARMY MEDICAL RESEARCH ACQU ISITION ACT 820 CHANDLER S
May 20, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013. or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-27545 QUICK-ME
May 17, 2013	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 form8k.htm QUICK MED TECHNOLOGIES INC 8-K 5-9-2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 17, 2013 (May 9, 2013) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-2754
May 17, 2013	EX-10.1	PATENT AND TECHNOLOGY LICENSE AGREEMENT Exhibit 10.1 PATENT AND TECHNOLOGY LICENSE AGREEMENT This Patent and Technology License Agreement ("Agreement"), effective April 1, 2013 ("Effective Date"), is by and between Quick-Med Technologies, Inc., a Nevada corporation having offices at 902 NW Fourth Street, Gainesville, Florida 32601, United States of America ("QMT") and VIRIDIS BioPharma Pvt. Ltd., an India corporation having offices at 6
May 17, 2013	EX-10.2	AMENDMENT No. 4 to the PATENT AND TECHNOLOGY LICENSE AGREEMENT of July 26, 2010; the AMENDMENT NO. 1 of December 2, 2011; the AMENDMENT NO. 2 of April 5, 2012; and the AMENDMENT No. 3 of December 17, 2012 Exhibit 10.2 AMENDMENT No. 4 to the PATENT AND TECHNOLOGY LICENSE AGREEMENT of July 26, 2010; the AMENDMENT NO. 1 of December 2, 2011; the AMENDMENT NO. 2 of April 5, 2012; and the AMENDMENT No. 3 of December 17, 2012 This fourth amendment to the Patent and Technology License Agreement of July 26, 2010 (“Agreement”) as amended by Amendment No.1 of December 2, 2011; Amendment No. 2 of April 5, 2012
May 15, 2013	NT 10-Q	- NONE United States Securities and Exchange Commission Washington, D.C. 20549 FORM 12b-25 Notification of Late Filing (Amendment No. 0)* OMB Number 3235-0058 SEC File Number CUSIP Number (Check one): Form 10-K Form 20-F Form 11-K √ Form 10-Q Form 10-D Form N-SAR Form N-CSR For Period Ended: March 31, 2013 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transi
April 16, 2013	EX-99.1	Quick-Med Engages Match Point Partners as Financial Advisor Subtitle: Specialist firm expert in healthcare markets served by QMT EX-99.1 2 ex991.htm EXHIBIT 99.1 Exhibit 99.1 News Release Quick-Med Engages Match Point Partners as Financial Advisor Subtitle: Specialist firm expert in healthcare markets served by QMT Gainesville, Florida – April 12, 2013. Quick-Med Technologies, Inc. (OTCQB: QMDT), a life sciences company, announced that is that it has retained Match Point Partners to manage its investor and public relations
April 16, 2013	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 16, 2013 QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction of incorporation) (Commissi
February 28, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - QUICK-MED TECHNOLOGIES INC. 8-K 2-28-2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2013 QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 98-0204736 (State or other jurisdiction of incorporation) (Commi
February 19, 2013	NT 10-Q/A	- NONE United States Securities and Exchange Commission Washington, D.C. 20549 FORM 12b-25 Notification of Late Filing (Amendment No. 1)* OMB Number 3235-0058 SEC File Number 000-27545 CUSIP Number 74837Q106 (Check one): Form 10-K Form 20-F Form 11-K √ Form 10-Q Form 10-D Form N-SAR Form N-CSR For Period Ended: December 31, 2012 Transition Report on Form 10-K Transition Report on Form 20-F Transition Rep
February 19, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2012. or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-27545 QUICK
February 15, 2013	NT 10-Q	- NONE United States Securities and Exchange Commission Washington, D.C. 20549 FORM 12b-25 Notification of Late Filing (Amendment No. 0)* OMB Number 3235-0058 SEC File Number 000-27545 CUSIP Number 74837Q106 (Check one): Form 10-K Form 20-F Form 11-K √ Form 10-Q Form 10-D Form N-SAR Form N-CSR For Period Ended: December 31, 2012 Transition Report on Form 10-K Transition Report on Form 20-F Transition Rep
February 1, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - DEPARTURE OF DIRECTOR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 1, 2013 QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Commission (IRS Employer
January 15, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - APPOINTMENT OF CHIEF FINANCIAL OFFICER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 15, 2013 QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Commission (IRS Employer
November 19, 2012	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012. or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-27545 QUIC
November 15, 2012	NT 10-Q	- NT QTR ENDED SEPTEMBER 30, 2012 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For the Period Ended: September 30, 2012 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A PART I – REGISTRANT INFORMATION
November 13, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - DEPARTURE OF DIRECTOR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2012 (November 6, 2012) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Comm
September 28, 2012	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [ X ] Annual Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended June 30, 2012 [ ] Transition Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number: 000-27545 QUICK-MED TECHNOLOGIES, INC. (Name of
August 2, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - APPOINTMENT OF PRESIDENT AND DIRECTOR AND RESIGNATION OF CEO AND VP OF R&D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2012 (July 27, 2012) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Commission
July 18, 2012	EX-10.1	PATENT AND TECHNOLOGY LICENSE AGREEMENT EXHIBIT 10.1 REDACTED COPY PATENT AND TECHNOLOGY LICENSE AGREEMENT This Patent and Technology License Agreement (“Agreement”), effective as of the 12th day of July, 2012 (the “Effective Date”), is by and between Quick-Med Technologies, Inc., a Nevada corporation having offices at 902 NW 4 Street, Gainesville, Florida 32601 (“QMT”) and Derma Sciences, Inc., a Pennsylvania corporation having offices
July 18, 2012	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 body8k.htm QUICK-MED AND DERMA SCIENCES LICENSE AGREEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 18, 2012 (July 12, 2012) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada
June 28, 2012	8-K/A	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 28, 2012 (November 17, 2011) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other ju
June 28, 2012	EX-10.1	PATENT AND TECHNOLOGY LICENSE AGREEMENT EXHIBIT 10.1 REDACTED COPY PATENT AND TECHNOLOGY LICENSE AGREEMENT This Patent and Technology License Agreement (“Agreement”), effective this 1st day of October 2011 (the “Effective Date”), is by and between Quick-Med Technologies, Inc., a Nevada corporation having offices at 902 NW Fourth Street, Gainesville, Florida 32601 (“QMT”) and Biosara Corporation., a Delaware corporation having offices at
May 16, 2012	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2012. or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-27545 QUICK-ME
May 16, 2012	NT 10-Q	- NOTICE OF LATE FILING - FORM 10-Q NT 10-Q 1 nt10q.htm NOTICE OF LATE FILING - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For the Period Ended: March 31, 2012 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notific
February 15, 2012	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2011. or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-27545 QUICK
February 15, 2012	NT 10-Q	- QUICK-MED TECHNOLOGIES FORM 12B-25 FOR 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For the Period Ended: December 31, 2011 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A PART I – REGISTRANT INFORMATION
January 6, 2012	10-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 ON FORM 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 ON FORM 10-K/A [ X ] Annual Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended June 30, 2011 [ ] Transition Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number: 000-27545 QUICK-MED TECHNOL
November 23, 2011	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 body8k.htm LICENSE AGREEMENT BETWEEN QUICK-MED TECHNOLOGIES AND BIOSARA CORPORATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 23, 2011 (November 17, 2011) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant a
November 23, 2011	EX-10.1	PATENT AND TECHNOLOGY LICENSE AGREEMENT EX-10.1 2 ex101.htm EXHIBIT 10.1 EXHIBIT 10.1 REDACTED COPY PATENT AND TECHNOLOGY LICENSE AGREEMENT This Patent and Technology License Agreement (“Agreement”), effective this 1st day of October 2011 (the “Effective Date”), is by and between Quick-Med Technologies, Inc., a Nevada corporation having offices at 902 NW Fourth Street, Gainesville, Florida 32601 (“QMT”) and Biosara Corporation., a Delaw
November 14, 2011	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2011. or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-27545 QUIC
September 29, 2011	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [ X ] Annual Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended June 30, 2011 [ ] Transition Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number: 000-27545 QUICK-MED TECHNOLOGIES, INC. (Name of
September 29, 2011	NT 10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR [ ] Form C-SAR For the Period Ended: June 30, 2011 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR [ ] Form C-SAR For the Period Ended: June 30, 2011 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A PART I ? REGISTRANT INFORMATION Full
August 8, 2011	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2011 (August 2, 2011) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Commissio
May 16, 2011	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2011. or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-27545 QUICK-ME
April 7, 2011	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 7, 2011 (April 1, 2011) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Commission (
April 7, 2011	EX-10.1	LICENSE AGREEMENT EXHIBIT 10.1 REDACTED COPY LICENSE AGREEMENT This LICENSE AGREEMENT (?Agreement?) is entered into and made effective April 1, 2011 (?Effective Date?) by and between Quick-Med Technologies, Inc., a Nevada corporation, having a business address of 902 NW Fourth Street, Gainesville, Florida 32601 (?Quick-Med?), and Avery Dennison Corporation, a Delaware corporation, acting through its Medical Solutio
February 14, 2011	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2010. or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-27545 QUICK
November 15, 2010	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2010. or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-27545 QUIC
September 29, 2010	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [ X ] Annual Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended June 30, 2010 [ ] Transition Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number: 000-27545 QUICK-MED TECHNOLOGIES, INC. (Name of
September 29, 2010	NT 10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 000-27545 NT 10-K 1 nt10k.htm NT FOR 10-K FISCAL YEAR 2010 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 000-27545 (Check One): [X] Form 10-K [] Form 20-F [] Form 11-K [] Form 10-Q [] Form N-SAR [] Form N-CSR For Period Ended: June 30, 2010 [] Transition Report on Form 10-K [] Transition Report on Form 20-F [] Transition
August 12, 2010	EX-10.1	DEVELOPMENT AND OPTION AGREEMENT EXHIBIT 10.1 REDACTED COPY DEVELOPMENT AND OPTION AGREEMENT This Development and Option Agreement (“Agreement”) is entered into as of August 6, 2010 (“Effective Date”) by and between Biosara Corporation, a Delaware corporation, with a principal place of business in Corinth, Texas (“Biosara”) and Quick-Med Technologies, Inc., a Nevada corporation, having its principal office at 902 NW 4th Street, G
August 12, 2010	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 12, 2010 (August 6, 2010) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Commissio
July 30, 2010	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 30, 2010 (July 26, 2010) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Commission (
July 30, 2010	EX-10.1	PATENT AND TECHNOLOGY LICENSE AGREEMENT EXHIBIT 10.1 REDACTED COPY PATENT AND TECHNOLOGY LICENSE AGREEMENT This Patent and Technology License Agreement (?Agreement?), effective this 26th day of July 2010 (the ?Effective Date?), is by and between Quick-Med Technologies, Inc., a Nevada corporation having offices at 902 NW Fourth Street, Gainesville, Florida 32601 (?QMT?) and Viridis BioPharma Pvt. Ltd., an India corpo ration having office
May 17, 2010	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2010. or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-27545 QUICK-ME
April 8, 2010	EX-10.1	DEVELOPMENT AGREEMENT EXHIBIT 10.1 REDACTED COPY DEVELOPMENT AGREEMENT THIS DEVELOPMENT AGREEMENT (this ?Agreement?) is made effective as of the 18th day of March, 2010 (the ?Effective Date?), by and between KCI USA, Inc., a Delaware corporation (?KCI?) and Quick-Med Technologies, Inc., a Nevada corporation (?Quick-Med?). 1. Definitions. The following terms shall be defined as follows when used herein: (a) ?Affiliate?
April 8, 2010	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 8, 2010 (April 2, 2010) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Commission (
April 6, 2010	EX-10.2	QUICK-MED TECHNOLOGIES, INC. SENIOR CONVERTIBLE PROMISSORY NOTE EXHIBIT 10.2 $150,000.00 0; March 31, 2010 QUICK-MED TECHNOLOGIES, INC. SENIOR CONVERTIBLE PROMISSORY NOTE FOR VALUE RECEIVED, the undersigned, QUICK-MED TECHNOLOGIES, INC. (the ?Borrower?), promises unconditionally to pay to the order of 2849232 CANADA INC its successors or assigns (the ?Lender?) at the Lender?s office at 2849232 CANADA INC, C/O Mark Appel, 38 Avenue Road #708, Toronto, Ontario
April 6, 2010	EX-10.3	QUICK-MED TECHNOLOGIES, INC. SENIOR CONVERTIBLE PROMISSORY NOTE EXHIBIT 10.3 $100,000.00 March 31, 2010 QUICK-MED TECHNOLOGIES, INC. SENIOR CONVERTIBLE PROMISSORY NOTE FOR VALUE RECEIVED, the undersigned, QUICK-MED TECHNOLOGIES, INC. (the “Borrower”), promises unconditionally to pay to the order of Peter L. Berry Holdings, Inc., its successors or assigns (the “Lender”) at the Lender’s office at 20 Forest 5 Len Cors, Toronto CANADA MAN 2E8 or at such other plac
April 6, 2010	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 6, 2010 (March 31, 2010) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Commission
April 6, 2010	EX-10.1	QUICK-MED TECHNOLOGIES, INC. SENIOR CONVERTIBLE PROMISSORY NOTE EXHIBIT 10.1 $1,053,000.00 &# 160; March 31, 2010 QUICK-MED TECHNOLOGIES, INC. SENIOR CONVERTIBLE PROMISSORY NOTE FOR VALUE RECEIVED, the undersigned, QUICK-MED TECHNOLOGIES, INC. (the “Borrower”), promises unconditionally to pay to the order of PHRONESIS PARTNERS, L.P., its successors or assigns (the “Lender”), at the Lender’s office at 130 E. Chestnut Street, Suite 403, Columbus, Ohio 43215, or
March 11, 2010	EX-10.1	LICENSE AGREEMENT by and between: Johnson & Johnson Consumer and Personal Products Worldwide, a division of Johnson & Johnson Consumer Companies, Inc. 199 Grandview Drive Skillman, New Jersey Quick-Med Technologies, Inc. 902 NW 4th Street Gainesville EXHIBIT 10.1 REDACTED COPY LICENSE AGREEMENT by and between: Johnson & Johnson Consumer and Personal Products Worldwide, a division of Johnson & Johnson Consumer Companies, Inc. 199 Grandview Drive Skillman, New Jersey and Quick-Med Technologies, Inc. 902 NW 4th Street Gainesville, Florida WHEREAS, Johnson & Johnson Consumer and Personal Products Worldwide, a division of Johnson & Johnson Consumer
March 11, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 11, 2010 (March 5, 2010) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 11, 2010 (March 5, 2010) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Commission
February 19, 2010	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 19, 2010 (February 12, 20 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 19, 2010 (February 12, 2010) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Comm
February 19, 2010	EX-10.1	Quick-Med Technologies, Inc. AMENDMENT NO. 2 TO PATENT AND TECHNOLOGY LICENSE AGREEMENT OF 23 MARCH 2007 EXHIBIT 10.1 Quick-Med Technologies, Inc. AMENDMENT NO. 2 TO PATENT AND TECHNOLOGY LICENSE AGREEMENT OF 23 MARCH 2007 This is the second amendment to the Patent and Technology License Agreement (?Agreement?), of 23 March 2007, as previously amended by Amendment No. 1 on 27 March 2009, made by and between: Quick-Med Technologies, Inc., a Nevada corporation having offices at 902 N.W. Fourth Street,
February 16, 2010	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2009. or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-27545 QUICK
November 16, 2009	EX-10.1	QUICK-MED TECHNOLOGIES, INC. 2009 SENIOR CONVERTIBLE PROMISSORY NOTE 3 $600,000.00 November 10, 2009 QUICK-MED TECHNOLOGIES, INC. 2009 SENIOR CONVERTIBLE PROMISSORY NOTE 3 FOR VALUE RECEIVED, the undersigned, QUICK-MED TECHNOLOGIES, INC. (the “Borrower”), promises unconditionally to pay to the order of Michael Granito, his successors or assigns (the “Lender”) at the Lender’s offices at 1088 Shady Avenue, Pittsburgh, Pennsylvania 15232, or at such other place as the L
November 16, 2009	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2009. or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-27545 QUIC
October 14, 2009	EX-10.1	JOINT DEVELOPMENT AND EXCLUSIVE OPTION AGREEMENT EXHIBIT 10.1 JOINT DEVELOPMENT AND EXCLUSIVE OPTION AGREEMENT This Joint Development and Exclusive Option Agreement (“Agreement”), effective as of the date signed by both parties (“Effective Date”), is entered into by and between AVERY DENNISON CORPORATION, a Delaware corporation having an address and contact person at 150 North Orange Grove Boulevard, Pasadena, California (“Avery”) and QUICK-MED
October 14, 2009	8-K/A	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 14, 2009 (April 17, 2009) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Commis
September 28, 2009	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [ X ] Annual Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended June 30, 2009 [ ] Transition Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission file number: 000-27545 QUICK-MED TECHNOLOGIES, INC. (Name of
September 28, 2009	EX-10.6.8	QUICK-MED TECHNOLOGIES, INC. 2009 SENIOR CONVERTIBLE PROMISSORY NOTE 2 0; EXHIBIT 10.6.8 $375,000.00 60; May 12, 2009 QUICK-MED TECHNOLOGIES, INC. 2009 SENIOR CONVERTIBLE PROMISSORY NOTE 2 FOR VALUE RECEIVED, the undersigned, QUICK-MED TECHNOLOGIES, INC. (the ?Borrower?), promises unconditionally to pay to the order of Michael Granito, his successors or assigns (the ?Lender?) at the Lender?s offices at 1088 Shady Avenue, Pittsburgh, Pennsylvania 15232, or at such o
May 15, 2009	EX-10.1	QUICK-MED TECHNOLOGIES, INC. 2009 SENIOR CONVERTIBLE PROMISSORY NOTE 1 0; EXHIBIT 10.1 $175,000.00 February 26, 2009 QUICK-MED TECHNOLOGIES, INC. 2009 SENIOR CONVERTIBLE PROMISSORY NOTE 1 FOR VALUE RECEIVED, the undersigned, QUICK-MED TECHNOLOGIES, INC. (the ?Borrower?), promises unconditionally to pay to the order of Michael Granito, his successors or assigns (the ?Lender?) at the Lender?s offices at 1088 Shady Avenue, Pittsburgh, Pennsylvania 15232, or at such othe
May 15, 2009	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2009. or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-27545 QUICK-ME
April 23, 2009	EX-10.1	JOINT DEVELOPMENT AND EXCLUSIVE OPTION AGREEMENT EX-10.1 2 ex101.htm JOINT DEVELOPMENT AND EXCLUSIVE OPTION AGREEMENT BY AND BETWEEN QUICK-MED AND AVERY DENNISON EXHIBIT 10.1 JOINT DEVELOPMENT AND EXCLUSIVE OPTION AGREEMENT This Joint Development and Exclusive Option Agreement (“Agreement”), effective as of the date signed by both parties (“Effective Date”), is entered into by and between AVERY DENNISON CORPORATION, a Delaware corporation having
April 23, 2009	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 23, 2009 (April 17, 2009) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Commission
March 19, 2009	CORRESP	March 19, 2009 March 19, 2009 Lynn Dicker Reviewing Accountant Division of Corporate Finance Securities and Exchange Commission Washington, D.
February 26, 2009	8-K	Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 26, 2009 QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Commission (IRS Employer
February 26, 2009	EX-99.1	FDA Clears First Quick-Med Product Innovative NIMBUS® Gauze Receives Special “De Novo” Clearance Brings Highly Effective, Non-Leaching, and Affordable Barrier Protection to the $14 Billion Global Wound Care Market EXHIBIT 99.1 FDA Clears First Quick-Med Product Innovative NIMBUS® Gauze Receives Special “De Novo” Clearance Brings Highly Effective, Non-Leaching, and Affordable Barrier Protection to the $14 Billion Global Wound Care Market Gainesville, Florida – February 26, 2009 – Quick-Med Technologies, Inc. announced today that it has received clearance from the U.S. Food and Drug Administration to market a
February 17, 2009	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2008. or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-27545 QUICK
February 17, 2009	CORRESP	Carrying Value Level 1 Level 2 Level 3 Financial Assets Cash Equivalents $xx,xxx $xx,xxx Total financial assets $xx,xxx February 17, 2009 Lynn Dicker Reviewing Accountant Division of Corporate Finance Securities and Exchange Commission Washington, D.
February 13, 2009	10-Q/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2008. or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Nu
January 27, 2009	DEF 14C	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ¨ Preliminary Information Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ý Definitive Information Statement QUICK-MED TECHNOLOGIES, INC. (Name o
November 14, 2008	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2008. or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-27545 QUIC
November 14, 2008	EX-10.6.4	QUICK-MED TECHNOLOGIES, INC. 2008 SENIOR CONVERTIBLE PROMISSORY NOTE 3 60; EXHIBIT 10.3 $150,000.00 September 15, 2008 QUICK-MED TECHNOLOGIES, INC. 2008 SENIOR CONVERTIBLE PROMISSORY NOTE 3 FOR VALUE RECEIVED, the undersigned, QUICK-MED TECHNOLOGIES, INC. (the ?Borrower?), promises unconditionally to pay to the order of Michael Granito, his successors or assigns (the ?Lender?) at the Lender?s offices at 1088 Shady Avenue, Pittsburgh, Pennsylvania 15232, or at such ot
September 29, 2008	EX-31.1.1	CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO THE SECURITIES EXCHANGE ACT OF 1934 RULE 13a-14(a)/15d-14(a) AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 EXHIBIT 31.1 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO THE SECURITIES EXCHANGE ACT OF 1934 RULE 13a-14(a)/15d-14(a) AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, J. Ladd Greeno, Chief Executive Officer of Quick-Med Technologies, Inc., certify that: 1. I have reviewed this annual report on Form 10-KSB for the fiscal year ended June 30, 2008 of Quick-Med Tech
September 29, 2008	EX-31.1.2	CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO THE SECURITIES EXCHANGE ACT OF 1934 RULE 13a-14(a)/15d-14(a) AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 EXHIBIT 31.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO THE SECURITIES EXCHANGE ACT OF 1934 RULE 13a-14(a)/15d-14(a) AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Nam H. Nguyen, Chief Financial Officer of Quick Med Technologies, Inc., certify that: 1. I have reviewed this annual report on Form 10-KSB for the fiscal year ended June 30, 2008 of Quick Med Technolog
September 29, 2008	EX-10.6.5	QUICK-MED TECHNOLOGIES, INC. 2008 SENIOR CONVERTIBLE PROMISSORY NOTE 2 EXHIBIT 10.6.5 $485,000.00 May 13, 2008 QUICK-MED TECHNOLOGIES, INC. 2008 SENIOR CONVERTIBLE PROMISSORY NOTE 2 FOR VALUE RECEIVED, the undersigned, QUICK-MED TECHNOLOGIES, INC. (the “Borrower”), promises unconditionally to pay to the order of Michael Granito, his successors or assigns (the “Lender”) at the Lender’s offices at 1088 Shady Avenue, Pittsburgh, Pennsylvania 15232, or at such other plac
September 29, 2008	10KSB	U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2008 Commission file number 000-27545 QUICK-MED TECHNOL ; U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2008 Commission file number 000-27545 QUICK-MED TECHNOLOGIES, INC. - (Name of registrant as specified in its charter) Nevada 65-0797243 (State or Other Jurisdiction of organization) (IRS Employer Identif
September 29, 2008	EX-32.2.2	CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 EXHIBIT 32.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the accompanying Annual Report on Form 10-KSB of Quick-Med Technologies, Inc. (the "Company") for the fiscal year ended June 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the "Report"),
September 29, 2008	EX-32.2.1	CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 EXHIBIT 32.1 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the accompanying Annual Report on Form 10-KSB of Quick-Med Technologies, Inc. (the "Company") for the fiscal year ended June 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the "Report
May 21, 2008	EX-10.1	MANUFACTURING AND DISTRIBUTION AGREEMENT EXHIBIT 10.1 MANUFACTURING AND DISTRIBUTION AGREEMENT This Manufacturing and Distribution Agreement (“Agreement”), effective this 1st day of August 2007 (the “Effective Date”), is made by and between Quick Med Technologies, Inc., with a registered office at 902 NW 4th Street, Gainesville, Florida 32601 (hereinafter “QMT”) and BASF Beauty Care Solutions, L.L.C., a member of the BASF Group, with a r
May 21, 2008	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 21, 2008 (May 16, 2008) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 21, 2008 (May 16, 2008) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Commission (IR
May 15, 2008	EX-10.3	QUICK-MED TECHNOLOGIES, INC. 2008 SENIOR CONVERTIBLE PROMISSORY NOTE 1 EXHIBIT 10.3 $370,000.00 February 11, 2008 QUICK-MED TECHNOLOGIES, INC. 2008 SENIOR CONVERTIBLE PROMISSORY NOTE 1 FOR VALUE RECEIVED, the undersigned, QUICK-MED TECHNOLOGIES, INC. (the “Borrower”), promises unconditionally to pay to the order of Michael Granito, his successors or assigns (the “Lender”) at the Lender’s offices at 1088 Shady Avenue, Pittsburgh, Pennsylvania 15232, or at such other p
May 15, 2008	10QSB	U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB x Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2008 Transition report under Section 13 or 15(d) of the Exchange Act for the Transition Period from to . Commission file number 0-27545 QUICK-MED TECHNOLOGIES, INC. (Exact Name of Small Business Issue
April 9, 2008	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 9, 2008 (April 4, 2008) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Commission (
April 9, 2008	EX-10.1	JOINT DEVELOPMENT AGREEMENT 60; &# 160; ; EXHIBIT 10.1 JOINT DEVELOPMENT AGREEMENT This Joint Development Agreement (“JDA”) is entered into as of March 19, 2008 (“Effective Date”) by and between Molnlycke Health Care AB, a corporation incorporated under the laws of Sweden, with a principal place of business in Gothenburg, Sweden (“MHC”) and Quick-Med Technologies, Inc., a Nevada corporation, having its principal office at 90
March 4, 2008	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2008 (February 29, 2008) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Commiss
February 14, 2008	EX-10.6.3	QUICK-MED TECHNOLOGIES, INC. SENIOR CONVERTIBLE PROMISSORY NOTE 2 EXHIBIT 10.6.3 $300,000.00 October 30, 2007 QUICK-MED TECHNOLOGIES, INC. SENIOR CONVERTIBLE PROMISSORY NOTE 2 FOR VALUE RECEIVED, the undersigned, QUICK-MED TECHNOLOGIES, INC. (the “Borrower”), promises unconditionally to pay to the order of Michael Granito, his successors or assigns (the “Lender”) at the Lender’s offices at 1088 Shady Avenue, Pittsburgh, Pennsylvania 15232, or at such other place
February 14, 2008	10QSB	U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB x Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended December 31, 2007 Transition report under Section 13 or 15(d) of the Exchange Act for the Transition Period from to . Commission file number 0-27545 QUICK-MED TECHNOLOGIES, INC. (Exact Name of Small Business Is
January 24, 2008	DEF 14C	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ¨ Preliminary Information Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ý Definitive Information Statement QUICK-MED TECHNOLOGIES, INC. (Name o
January 18, 2008	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 18, 2008 (January 18, 2008) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Commi
January 10, 2008	PRE 14C	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Page1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ? Preliminary Information Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ? Definitive Information Statement QUICK-MED TECHNOLOGIES, INC. (
November 14, 2007	10QSB	U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB x Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2007 Transition report under Section 13 or 15(d) of the Exchange Act for the Transition Period from to . Commission file number 0-27545 QUICK-MED TECHNOLOGIES, INC. (Exact Name of Small Business I
October 5, 2007	EX-10.7	QUICK-MED TECHNOLOGIES, INC. SENIOR CONVERTIBLE PROMISSORY NOTE EXHIBIT 10.7 $375,000.00 June 27, 2007 QUICK-MED TECHNOLOGIES, INC. SENIOR CONVERTIBLE PROMISSORY NOTE THIS PROMISSORY NOTE IS SUBJECT TO THE PROVISIONS OF A CERTAIN INTERCREDITOR AGREEMENT DATED AS OF SEPTEMBER 27, 2007 AMONG MICHAEL GRANITO, PHRONESIS PARTNERS, L.P. AND QUICK-MED TECHNOLOGIES, INC. FOR VALUE RECEIVED, the undersigned, QUICK-MED TECHNOLOGIES, INC. (the “Borrower”), promises uncon
October 5, 2007	EX-10.8	LICENSE AGREEMENT University of Michigan Files 1175, 1356, 1442, 1442d1, 1442d3, 1543, 1543d1, 1720, 2044 and 2115 EXHIBIT 10.8 LICENSE AGREEMENT University of Michigan Files 1175, 1356, 1442, 1442d1, 1442d3, 1543, 1543d1, 1720, 2044 and 2115 This Agreement is effective as of May 24, 2007 (the "Effective Date"), between Quick-Med Technologies, Inc. ("LICENSEE") having the address in Article 13 below, and the Regents of the University of Michigan, a constitutional corporation of the State of Michigan ("MICHIGAN
October 5, 2007	10KSB/A	U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDEMENT NO. 1 ON FORM 10-KSB/A ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2007 Commission file number 000-2 U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDEMENT NO. 1 ON FORM 10-KSB/A ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2007 Commission file number 000-27545 QUICK-MED TECHNOLOGIES, INC. - (Name of registrant as specified in its charter) Nevada 65-0797243 (State or Other Jurisdiction of organization) (
October 5, 2007	EX-10.6.2	QUICK-MED TECHNOLOGIES, INC. SENIOR CONVERTIBLE PROMISSORY NOTE EXHIBIT 10.6.2 $375,000.00 June 14, 2007 QUICK-MED TECHNOLOGIES, INC. SENIOR CONVERTIBLE PROMISSORY NOTE THIS PROMISSORY NOTE IS SUBJECT TO THE PROVISIONS OF A CERTAIN INTERCREDITOR AGREEMENT DATED AS OF SEPTEMBER 27, 2007 AMONG MICHAEL GRANITO, PHRONESIS PARTNERS, L.P. AND QUICK-MED TECHNOLOGIES, INC. FOR VALUE RECEIVED, the undersigned, QUICK-MED TECHNOLOGIES, INC. (the “Borrower”), promises unc
October 5, 2007	EX-10.6.1	SENIOR CONVERTIBLE PROMISSORY NOTE ; 60; EXHIBIT 10.6.1 $208,954.88 June 14, 2007 QUICK-MED TECHNOLOGIES, INC. SENIOR CONVERTIBLE PROMISSORY NOTE FOR VALUE RECEIVED, the undersigned, QUICK-MED TECHNOLOGIES, INC. (the “Borrower”), promises unconditionally to pay to the order of Michael Granito, his successors or assigns (the “Lender”) at the Lender’s office at 1088 Shady Avenue, Pittsburgh, Pennsylvania 15232, or at such other pla
September 28, 2007	EX-10.8	LICENSE AGREEMENT University of Michigan Files 1175, 1356, 1442, 1442d1, 1442d3, 1543, 1543d1, 1720, 2044 and 2115 LICENSE AGREEMENT University of Michigan Files 1175, 1356, 1442, 1442d1, 1442d3, 1543, 1543d1, 1720, 2044 and 2115 This Agreement is effective as of May 24, 2007 (the "Effective Date"), between Quick-Med Technologies, Inc.
September 28, 2007	EX-10.6.2	QUICK-MED TECHNOLOGIES, INC. SENIOR CONVERTIBLE PROMISSORY NOTE $375,000.00 June 14, 2007 QUICK-MED TECHNOLOGIES, INC. SENIOR CONVERTIBLE PROMISSORY NOTE THIS PROMISSORY NOTE IS SUBJECT TO THE PROVISIONS OF A CERTAIN INTERCREDITOR AGREEMENT DATED AS OF SEPTEMBER 27, 2007 AMONG MICHAEL GRANITO, PHRONESIS PARTNERS, L.P. AND QUICK-MED TECHNOLOGIES, INC. FOR VALUE RECEIVED, the undersigned, QUICK-MED TECHNOLOGIES, INC. (the “Borrower”), promises unconditionally to
September 28, 2007	10KSB	U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2007 Commission file number 000-27545 QUICK-MED TECHNOL U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2007 Commission file number 000-27545 QUICK-MED TECHNOLOGIES, INC. - (Name of registrant as specified in its charter) Nevada 65-0797243 (State or Other Jurisdiction of organization) (IRS Employer Identific
September 28, 2007	EX-10.6.1	SENIOR CONVERTIBLE PROMISSORY NOTE $208,954.88 June 14, 2007 QUICK-MED TECHNOLOGIES, INC. SENIOR CONVERTIBLE PROMISSORY NOTE FOR VALUE RECEIVED, the undersigned, QUICK-MED TECHNOLOGIES, INC. (the “Borrower”), promises unconditionally to pay to the order of Michael Granito, his successors or assigns (the “Lender”) at the Lender’s office at 1088 Shady Avenue, Pittsburgh, Pennsylvania 15232, or at such other place as the Lender may fr
September 28, 2007	EX-10.7	QUICK-MED TECHNOLOGIES, INC. SENIOR CONVERTIBLE PROMISSORY NOTE $375,000.00 June 27, 2007 QUICK-MED TECHNOLOGIES, INC. SENIOR CONVERTIBLE PROMISSORY NOTE THIS PROMISSORY NOTE IS SUBJECT TO THE PROVISIONS OF A CERTAIN INTERCREDITOR AGREEMENT DATED AS OF SEPTEMBER 27, 2007 AMONG MICHAEL GRANITO, PHRONESIS PARTNERS, L.P. AND QUICK-MED TECHNOLOGIES, INC. FOR VALUE RECEIVED, the undersigned, QUICK-MED TECHNOLOGIES, INC. (the “Borrower”), promises unconditionally to
September 11, 2007	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 7, 2007 (September 7, 2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 7, 2007 (September 7, 2007) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Com
August 10, 2007	EX-10.1	QUICK-MED TECHNOLOGIES, INC. LADD GREENO EMPLOYMENT AGREEMENT QUICK-MED TECHNOLOGIES, INC. LADD GREENO EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”) is entered into as of August 6, 2007 (the “Effective Date”) by and between Quick-Med Technologies, Inc. (the “Company”) and J. Ladd Greeno (“Executive”). 1. Duties and Scope of Employment. (a) Positions and Duties. Executive began employment with the Company on June 11, 2007 (the “Start Date”)
August 10, 2007	8-K	Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2007 (August 6, 2007) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 98-0204736 (State or other jurisdiction of incorp
May 15, 2007	10QSB	U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB x Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2007 Transition report under Section 13 or 15(d) of the Exchange Act for the Transition Period from to . Commission file number 0-27545 QUICK-MED TECHNOLOGIES, INC. (Exact Name of Small Business Issue
April 2, 2007	EX-10.1	PATENT AND TECHNOLOGY LICENSE AGREEMENT PATENT AND TECHNOLOGY LICENSE AGREEMENT This Patent and Technology License Agreement (“Agreement”), effective this 23 day of March 2007 (the “Effective Date”), is by and between Quick-Med Technologies, Inc.
April 2, 2007	8-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 2, 2007 (March 29, 2007) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 2, 2007 (March 29, 2007) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Commissio
March 29, 2007	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 29, 2007 (March 23, 2007) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 29, 2007 (March 23, 2007) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Commission
March 29, 2007	EX-10.1	PATENT AND TECHNOLOGY LICENSE AGREEMENT EX-10.1 2 ex101.htm LICENSE AGREEMENT BETWEEN QUICK-MED TECHNOLOGIES AND DERMA SCIENCES INC. EXHIBIT 10.1 REDACTED COPY PATENT AND TECHNOLOGY LICENSE AGREEMENT This Patent and Technology License Agreement (“Agreement”), effective this 23rd day of March 2007 (the “Effective Date”), is by and between Quick-Med Technologies, Inc., a Delaware corporation having offices at 3427 SW 42nd Way, Gainesville
February 15, 2007	NT 10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-27545 CUSIP NUMBER 74837Q106 (Check one): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR [ ] Form C-SAR For the Period Ended: December 31, 2006 If the notification relates to a portion of the filing checked above, identify the Item(s) to which
February 15, 2007	10QSB	U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB x Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended December 31, 2006 Transition report under Section 13 or 15(d) of the Exchange Act for the Transition Period from to . Commission file number 0-27545 QUICK-MED TECHNOLOGIES, INC. (Exact Name of Small Business Is
February 9, 2007	EX-10.1	DEVELOPMENT AND EXCLUSIVE OPTION AGREEMENT EXHIBIT 10.1 DEVELOPMENT AND EXCLUSIVE OPTION AGREEMENT This Development and Exclusive Option Agreement (this “Agreement”), effective as of February 1st, 2007 (the “Effective Date”) is entered into by and between HANESBRANDS INC., having an address and contact person at 1000 East Hanes Mill Road, Winston-Salem, North Carolina 27105 (Attention: Mike Abbott) (“HBI”) and QUICK-MED TECHNOLOGIES, INC.,
February 9, 2007	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 9, 2007 (February 5, 2007 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 9, 2007 (February 5, 2007) QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 65-0797243 (State or other jurisdiction (Commis
November 14, 2006	10QSB	U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB x Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2006 Transition report under Section 13 or 15(d) of the Exchange Act for the Transition Period from to . Commission file number 0-27545 QUICK-MED TECHNOLOGIES, INC. (Exact Name of Small Business I
November 14, 2006	EX-10.2	THIS AGREEMENT made effective from the first (1st) day of November, 2006, BETWEEN: 60; EXHIBIT 10.2 EMPLOYMENT CONTRACT THIS AGREEMENT made effective from the first (1st) day of November, 2006, BETWEEN: QUICK-MED TECHNOLOGIES, INC., a corporation existing under the laws of the State of Nevada, with its head office in the City of Gainesville, in the State of Florida (hereinafter referred to as the "Company") - and - GERALD M. OLDERMAN, an individual resident in the City of Bedfor
September 28, 2006	10KSB	U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2006 Commission file number 000-27545 QUICK-MED TECHNOLOGIES, INC. - (Name of registrant as specified in its charter) Nevada 98-0204736 (State or Other Jurisdiction of organization) (IRS Employer Identific
September 25, 2006	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 18, 2006 QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 98-0204736 (State or other jurisdiction (Commission (IRS Employe
September 25, 2006	EX-10.1	ITEM NO SECTION SF 30 BLOCK 14 CONTINUATION PAGE SUMMARY OF CHANGES SECTION A - SOLICITATION/CONTRACT FORM The total cost of this contract was increased by $769,999.
August 11, 2006	EX-10.7	FOURTH AMENDMENT TO LETTER OF INTENT EXHIBIT 10.7 FOURTH AMENDMENT TO LETTER OF INTENT It is hereby agreed as of June 30th, 2006 by and between Quick Med Technologies, Inc. (“Quick Med”) and Engelhard Long Island, Inc. (“Engelhard”) (collectively referred to as “the parties”) that: 1. Reference is hereby made to the Letter of Intent effective February 1, 2006 (the “Original LOI) entered into between Engelhard and Quick Med, as amende
August 11, 2006	EX-10.6	THIRD AMENDMENT TO LETTER OF INTENT EXHIBIT 10.6 THIRD AMENDMENT TO LETTER OF INTENT It is hereby agreed as of June 13, 2006 by and between Quick Med Technologies, Inc. (“Quick Med”) and Engelhard Long Island, Inc. (“Engelhard”) (collectively referred to as “the parties”) that: 1. Reference is hereby made to the Letter of Intent effective February 1, 2006 (the “LOI”) entered into between Engelhard and Quick Med. 2. Sections 2,3 and
August 11, 2006	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 30, 2006 QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 000-27545 98-0204736 (State or other jurisdiction (Commission (IRS Employer of
August 11, 2006	EX-10.4	FIRST AMENDMENT TO LETTER OF INTENT EXHIBIT 10.4 FIRST AMENDMENT TO LETTER OF INTENT It is hereby agreed as of April 26, 2006 by and between Quick Med Technologies, Inc. (“Quick Med”) and Engelhard Long Island, Inc. (“Engelhard”) (collectively referred to as “the parties”) that: 1. Reference is hereby made to the Letter of Intent effective February 1, 2006 (the “LOI”) entered into between Engelhard and Quick Med. 2. Sections 2,3 and
August 11, 2006	EX-10.2	LETTER OF INTENT EXHIBIT 10.2 LETTER OF INTENT This Letter of Intent is effective this 1st day of February, 2006, by and between Englehard Long Island Inc. with a registered office at 50 Health Sciences Drive, Stony Brook, NY 11790 (?Licensee?) and Quick Med Technologies, Inc., with a registered office at 3427 SW 42nd Way, Gainesville, Florida 32608 (?Licensor?), relating to the possible licensing of Licensor?s pr
August 11, 2006	EX-10.3	APPENDIX A Term Sheet EXHIBIT 10.3 APPENDIX A Term Sheet Definitions “Active(s)” shall mean *** designed by Engelhard * and does not mean the Licensed Compound. “Anti-Aging Cosmetics” shall mean a cosmetic product in which anti-aging is at least one of the product claims. “* Formulation(s)” shall mean any formulation that contains ***, excipient(s), and aesthetic modifier(s) and is a consumer-ready product.
August 11, 2006	EX-10.5	SECOND AMENDMENT TO LETTER OF INTENT EXHIBIT 10.5 SECOND AMENDMENT TO LETTER OF INTENT It is hereby agreed as of May 26, 2006 by and between Quick Med Technologies, Inc. (“Quick Med”) and Engelhard Long Island, Inc. (“Engelhard”) (collectively referred to as “the parties”) that: 1. Reference is hereby made to the Letter of Intent effective February 1, 2006 (the “LOI”) entered into between Engelhard and Quick Med. 2. Sections 2,3 and
May 12, 2006	10QSB	U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB x Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2006 Transition report under Section 13 or 15(d) of the Exchange Act for the Transition Period from to . Commission file number 0-27545 QUICK-MED TECHNOLOGIES, INC. (Exact Name of Small Business Issue
April 14, 2006	S-8	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 QUICK-MED TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Nevada 98-0204736 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 3427 SW 42nd Way Gainesville, Florida 32608 32608 (Address of
April 14, 2006	EX-4.1	=========================================================================== QUICK-MED TECHNOLOGIES, INC. AMENDED AND RESTATED 2001 EQUITY INCENTIVE PLAN & #160; Exhibit 4.1 =========================================================================== QUICK-MED TECHNOLOGIES, INC. AMENDED AND RESTATED 2001 EQUITY INCENTIVE PLAN =========================================================================== As approved by the Board of Directors on March 4, 2001, and as amended and restated with the approval of the Board of Directors on October 31, 2004. 1.
April 14, 2006	EX-4.2	Void after 5:00 p.m. Eastern Time on [INSERT EXPIRATION DATE] Warrant to Purchase Shares of Common Stock & #160; Exhibit 4.2 Void after 5:00 p.m. Eastern Time on [INSERT EXPIRATION DATE] Warrant to Purchase Shares of Common Stock THESE SECURITIES HAVE NOT BEEN REGISTERED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY OTHER JURISDICTION. THESE SECURITIES HAVE BEEN ISSUED PURSUANT TO EXEMPTIONS FROM REGISTRATION AND PROSPECTUS REQUIREMENTS PROVIDED BY (i) REGULATIO
February 14, 2006	10QSB	U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB x Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended December 31, 2005 Transition report under Section 13 or 15(d) of the Exchange Act for the Transition Period from to . Commission file number 0-27545 QUICK-MED TECHNOLOGIES, INC. (Exact Name of Small Business Is
January 4, 2006	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 15, 2005 Date of Report (Date of earliest reported event) QUICK-MED TECHNOLOGIES, INC.
December 30, 2005	DEF 14C	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: o Preliminary Information Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ? Definitive Information Statement QUICK-MED TECHNOLOGIES, INC. (Name o
December 20, 2005	PRE 14C	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ý Preliminary Information Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ¨ Definitive Information Statement QUICK-MED TECHNOLOGIES, INC. (Name o
November 21, 2005	10QSB	U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10Q-SB U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10Q-SB x Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2005 Transition report under Section 13 or 15(d) of the Exchange Act for the Transition Period from to . Commission file number 0-27545 QUICK-MED TECHNOLOGIES, INC. (Exact Name of Small Business I
November 21, 2005	EX-10.10	UNIT PRICE Section A - Solicitation/Contract Form GOVERNMENT CONTACTS Contract Specialist: U.
November 14, 2005	NT 10-Q	(a) The reasons described in detail in Part III of this form could not be eliminated without unreasonable effort or expense; SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-27545 CUSIP NUMBER 74837Q106 \| \| Form 10-K \| \| Form 20-F \| \| Form 11-K \|X\| Form 10-Q \| \| Form NSAR \| \| Form N-CSR For the period ended: September 30, 2005 \| \| Transition Report on Form 10-K \| \| Transition Report on Form 20-F \| \| Transition Report on Form 11-K \| \| Transition Report on Form 10-Q \| \| Transition Report on Form NSAR For the transition period ended: Read attached Instruction Sheet Before Preparing Form.
September 28, 2005	10KSB	U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2005 Commission file number 000-27545 QUICK-MED TECHNOL U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2005 Commission file number 000-27545 QUICK-MED TECHNOLOGIES, INC. - (Name of registrant as specified in its charter) Nevada 98-0204736 (State or Other Jurisdiction of organization) (IRS Employer Identific
January 4, 2005	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 31, 2004 Date of Report (Date of earliest reported event) QUICK-MED TECHNOLOGIES, INC.
December 3, 2004	EX-10.4	WARRANT TO PURCHASE SHARES OF COMMON STOCK QUICK-MED TECHNOLOGIES, INC. Exhibit 4 NEITHER THIS WARRANT NOR ANY OF THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAW.
December 3, 2004	EX-10.5	CONVERSION AGREEMENT Exhibit 5 CONVERSION AGREEMENT THIS CONVERSION AGREEMENT (this “Agreement”) dated as of November 30, 2004 is made and entered into by and between QUICK-MED TECHNOLOGIES, INC.
December 3, 2004	EX-10.1	STOCK PURCHASE AGREEMENT By and Between QUICK-MED TECHNOLOGIES, INC. PHRONESIS PARTNERS, LP Dated as of November 30, 2004 Exhibit 1 STOCK PURCHASE AGREEMENT By and Between QUICK-MED TECHNOLOGIES, INC. and PHRONESIS PARTNERS, LP Dated as of November 30, 2004 #405601v9 00000.00850 STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of November 30, 2004, is made and entered into by and between QUICK-MED TECHNOLOGIES, INC., a Nevada corporation (the “Company”), and PHRONESIS PARTNERS, L.P.
December 3, 2004	EX-10.6	CONFIDENTIALITY AND NONDISCLOSURE AGREEMENT Exhibit 6 CONFIDENTIALITY AND NONDISCLOSURE AGREEMENT THIS CONFIDENTIALITY AND NONDISCLOSURE AGREEMENT (the “Agreement”) is made and entered into as of November 30, 2004, by and between QUICK-MED TECHNOLOGIES, INC.
December 3, 2004	EX-10.2	QUICK-MED TECHNOLOGIES, INC. STOCKHOLDERS AGREEMENT IAP ACQUISITION CORPORATION Exhibit 2 QUICK-MED TECHNOLOGIES, INC. STOCKHOLDERS AGREEMENT THIS STOCKHOLDERS AGREEMENT (this “Agreement”) is made and entered into as of November 30, 2004, by and among QUICK-MED TECHNOLOGIES, INC., a Nevada corporation (the “Company”), PHRONESIS PARTNERS, L.P., a Delaware limited partnership (“Phronesis”), MICHAEL R. GRANITO, an individual (“Granito”), and DAVID S.
December 3, 2004	8-K	UNITED STATES UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 30, 2004 Date of Report (Date of earliest reported event) QUICK-MED TECHNOLOGIES, INC.
December 3, 2004	EX-10.3	REGISTRATION RIGHTS AGREEMENT Exhibit 3 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of November 30, 2004, by and among QUICK-MED TECHNOLOGIES, INC.
November 19, 2004	10QSB	U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10Q-SB U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10Q-SB X Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2004 Transition report under Section 13 or 15(d) of the Exchange Act for the Transition Period from to . Commission file number 0-27545 QUICK-MED TECHNOLOGIES, INC. (Exact Name of Small Business I
November 15, 2004	NT 10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Notice of Late Filing 12b-25 28JUN27,02 (C0075129.DOC;1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0058 Expires: March 31, 2006 Estimated average burden hours per response 2.50 FORM 12b-25 SEC FILE NUMBER 000-27545 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check One): ¨ Form 10-KSB ¨ Form 20-F ¨ Form 11-K x Form 10-QSB ¨ Form N-SAR 74837Q
October 21, 2004	10KSB/A	10KSB/A Form 10-KSB/A Quick-Med Technologies, Inc. Form 10-KSB/A QUICK-MED TECHNOLOGIES, INC. Amendment No. 1 to Annual Report filed by Small Businesses U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 - FORM 10-KSB/A AMENDED ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2004 Commission file number 000-27545 QUICK-MED
October 13, 2004	10KSB	10KSB Form 10-KSB Quick-Med Technologies, Inc. Form 10-KSB QUICK-MED TECHNOLOGIES, INC. Annual report filed by small businesses U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 - FORM 10-KSB ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2004 Commission file number 000-27545 QUICK-MED TECHNOLOGIES, INC. (Name of Small
September 28, 2004	NT 10-K	NT 10-K OMB Number: 3235-0058 Expires: March 31, 2006 Estimated average burden hours per response.
May 17, 2004	10QSB	10QSB U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [X] Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2004 [ ] Transition report under Section 13 or 15(d) of the Exchange Act for the Transition Period from to Commission file number 0-27545 QUICK-MED TECHNOLOGIES, INC. (Exact Name of Small Business I
February 17, 2004	10QSB	10QSB Quick-Med Technologies, Inc. Form 10-QSB U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [X] Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended December 31, 2003 [ ] Transition report under Section 13 or 15(d) of the Exchange Act for the Transition Period from to . Commission file number 0-27545 QUICK-MED TECH
November 19, 2003	EX-10	EX-10 Exhibit 10.9 Terms for a Distribution Agreement Between Noville and Quick-Med Technologies, Inc. November 17th, 2003 1. Noville will provide to QMT technical and scientific support services and infrastructure for developing its NIMBUS technology as one or more Products to be sold within the Business. Such services will include: o Pilot plant facilities for developing products (in South Plainfield,
November 19, 2003	10QSB	10QSB U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [X] Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2003 [ ] Transition report under Section 13 or 15(d) of the Exchange Act for the Transition Period from to . Commission file number 0-27545 QUICK-MED TECHNOLOGIES, INC. (Exact Name of Small Busi
November 12, 2003	NT 10-Q	NT 10-Q NT 10-Q 1 quickmednt10qsb.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING COMMISSION FILE NUMBER 333-41672 CUSIP NUMBER 74837Q 10 6 (Check One): []Form 10-K []Form 11-K []Form 20-F [X]Form 10-QSB For Period Ended: September 30, 2003 Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

QMDT / Quick-Med Technologies, Inc. - SEC-arkiveringar, Årsredovisning, Fullmaktsutlåtande

Grundläggande statistik

SEC Filings

SEC Filings (Chronological Order)